Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosis.

Murray PS, Kirkwood CM, Gray MC, Fish KN, Ikonomovic MD, Hamilton RL, Kofler JK, Klunk WE, Lopez OL, Sweet RA.

J Alzheimers Dis. 2014;39(4):759-73. doi: 10.3233/JAD-131166.

PMID:
24270207
[PubMed - in process]
2.

Psychosis in Alzheimer's disease.

Murray PS, Kumar S, Demichele-Sweet MA, Sweet RA.

Biol Psychiatry. 2014 Apr 1;75(7):542-52. doi: 10.1016/j.biopsych.2013.08.020. Epub 2013 Oct 6.

PMID:
24103379
[PubMed - in process]
3.

Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities.

Koppel J, Acker C, Davies P, Lopez OL, Jimenez H, Azose M, Greenwald BS, Murray PS, Kirkwood CM, Kofler J, Sweet RA.

Neurobiol Aging. 2014 Sep;35(9):2021-8. doi: 10.1016/j.neurobiolaging.2014.03.003. Epub 2014 Mar 6.

PMID:
24731519
[PubMed - in process]
4.

Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.

Hampel H, Mitchell A, Blennow K, Frank RA, Brettschneider S, Weller L, Möller HJ.

J Neural Transm. 2004 Mar;111(3):247-72. Epub 2003 Dec 3. Review.

PMID:
14991453
[PubMed - indexed for MEDLINE]
5.

Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease.

Koppel J, Jimenez H, Azose M, D'Abramo C, Acker C, Buthorn J, Greenwald BS, Lewis J, Lesser M, Liu Z, Davies P.

Behav Brain Res. 2014 Aug 20;275C:27-33. doi: 10.1016/j.bbr.2014.08.030. [Epub ahead of print]

PMID:
25151619
[PubMed - as supplied by publisher]
6.

Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J.

Curr Alzheimer Res. 2005 Jan;2(1):3-18. Review.

PMID:
15977985
[PubMed - indexed for MEDLINE]
7.

Regulation of tau phosphorylation in Alzheimer's disease.

Lee VM.

Ann N Y Acad Sci. 1996 Jan 17;777:107-13. Review.

PMID:
8624072
[PubMed - indexed for MEDLINE]
8.

Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.

Muntané G, Dalfó E, Martinez A, Ferrer I.

Neuroscience. 2008 Apr 9;152(4):913-23. doi: 10.1016/j.neuroscience.2008.01.030. Epub 2008 Feb 5.

PMID:
18343584
[PubMed - indexed for MEDLINE]
9.

A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.

Hurtado DE, Molina-Porcel L, Iba M, Aboagye AK, Paul SM, Trojanowski JQ, Lee VM.

Am J Pathol. 2010 Oct;177(4):1977-88. doi: 10.2353/ajpath.2010.100346. Epub 2010 Aug 27.

PMID:
20802182
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.

Apostolova LG, Hwang KS, Kohannim O, Avila D, Elashoff D, Jack CR Jr, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2014 Jan 4;4:461-72. doi: 10.1016/j.nicl.2013.12.012. eCollection 2014.

PMID:
24634832
[PubMed]
Free PMC Article
11.

Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.

Boche D, Donald J, Love S, Harris S, Neal JW, Holmes C, Nicoll JA.

Acta Neuropathol. 2010 Jul;120(1):13-20. doi: 10.1007/s00401-010-0705-y. Epub 2010 Jun 9.

PMID:
20532897
[PubMed - indexed for MEDLINE]
12.

Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.

Navarrete LP, Pérez P, Morales I, Maccioni RB.

Curr Alzheimer Res. 2011 Sep;8(6):678-85. Review.

PMID:
21605038
[PubMed - indexed for MEDLINE]
13.

Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau.

Ray B, Reyes PF, Lahiri DK.

J Psychiatr Res. 2011 Apr;45(4):539-47. doi: 10.1016/j.jpsychires.2010.07.011. Epub 2010 Sep 9.

PMID:
20828718
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.

Lonskaya I, Shekoyan AR, Hebron ML, Desforges N, Algarzae NK, Moussa CE.

J Alzheimers Dis. 2013;33(1):231-47. doi: 10.3233/JAD-2012-121141.

PMID:
22954671
[PubMed - indexed for MEDLINE]
15.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

PMID:
15324364
[PubMed - indexed for MEDLINE]
16.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
[PubMed - indexed for MEDLINE]
17.

Accumulation of intraneuronal β-amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses.

Takahashi RH, Capetillo-Zarate E, Lin MT, Milner TA, Gouras GK.

PLoS One. 2013;8(1):e51965. doi: 10.1371/journal.pone.0051965. Epub 2013 Jan 23.

PMID:
23372648
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
[PubMed - indexed for MEDLINE]
19.

White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.

Guzman VA, Carmichael OT, Schwarz C, Tosto G, Zimmerman ME, Brickman AM; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2013 Oct;9(5 Suppl):S124-31. doi: 10.1016/j.jalz.2012.11.009. Epub 2013 Jan 30.

PMID:
23375566
[PubMed - indexed for MEDLINE]
20.

Neurobiology of Alzheimer's disease.

Mohandas E, Rajmohan V, Raghunath B.

Indian J Psychiatry. 2009 Jan;51(1):55-61. doi: 10.4103/0019-5545.44908.

PMID:
19742193
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk